When you combine the appetite suppression of a GLP-1 with the high-intensity demands of HYROX or DEKA training, you create a metabolic "clash" that can stall your progress and break your body down
GLP-1 receptor agonists mimic a naturally occurring gut hormone called glucagon-like peptide-1 (GLP-1), which slows how quickly food moves from your stomach into your small intestine
Although GLP-1RAs have shown remarkable efficacy in weight management, several barriers limit their full integration into mainstream obesity care
By binding to GLP-1 receptors, semaglutide stimulates insulin release in response to high blood sugar levels and inhibits glucagon secretion, thereby lowering blood glucose
It is intended strictly for in-vitro laboratory research use only
it is contraindicated in those with a history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal disease, or a family history of pancreatitis